A Study to Evaluate Safety, Tolerability of Subcutaneous Injection in Adult Subjects Undergoing Abdominoplasty

Status:
Not yet recruiting

Trial end date:
2023-01-01

Target enrollment:

Participant gender:

Dose-ranging, randomized, double-blind, vehicle-controlled study

Phase 1

Sirnaomics